NCCN 2013 Oncology Pharmacy Best Practices Webinar Series: Legislative Issues in Oncology Care

April 5, 2013

Pharmacists are important to the clinical decision-making process, both at the individual patient level and the drug use policy level. At the individual patient level, the oncology multidisciplinary team typically includes a clinical pharmacist who specializes in oncology. Furthermore, pharmacists dispensing chemotherapy require the clinical knowledge and expertise to effectively assess the appropriateness of therapy (i.e., for indication, dosing, etc.) and monitor the patient for adverse effects. Pharmacists also must be knowledgeable about specific drugs to be able to effectively counsel a patient regarding medications. At the policy level, pharmacists are actively involved in the formation of drug use policy though their participation on Pharmacy & Therapeutics committees for hospitals and managed care organizations. Often, the pharmacist on the committee performs the literature review and writes the policy for the committee to approve.

Target Audience

This educational program is designed to meet the educational needs of pharmacists.

Learning Objectives

Following this activity, participants should be able to:

  • Describe legislative ‘fixes’ for drug shortages
  • Discuss legislation’s role in the incorporation of biosimilars into clinical practice
Additional information
Supporters: 

This activity is supported by an educational donation from Amgen.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Pharmacist
Course opens: 
04/05/2013
Course expires: 
08/31/2013
Event starts: 
04/05/2013 - 11:00am
Event ends: 
04/05/2013 - 12:00pm
Cost:
$0.00

Mark Smith
Liberty Partners Group, LLC

Available Credit

  • 1.00 Participation
  • 1.00 Pharmacist

Accreditation Period

Course opens: 
04/05/2013
Course expires: 
08/31/2013

Price

Cost:
$0.00
Please login or register to take this course.